You are here
- Home
- Last 30 days trials
(OSKIRA-X): A Long-term Extension Study to Assess the Safety and Efficacy of Fostamatinib Disodium in the Treatment of Rheumatoid Arthritis
- Disease
- rheumatoid arthritis
- Drug Name
- Fostamatinib Disodium
- Generic Name
- Fostamatinib
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- III
- Start Date
- Jan 10, 2011
- Study Name
- D4300C00005
- Study Id
- D4300C00005
- ClinicalTrials.gov ID
- NCT01242514
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
